SCMP News2 hours agoBusiness1 min readChina

How competition between Chinese and Indian firms could reshape Africa’s drug markets

Chinese antimalarial exports to 12 hard-hit African countries nearly matched India's last year, according to a new study.

Quick Look

China is challenging India's long-held dominance in the African antimalarial drug market, with Chinese exports reaching $89.3 million last year and nearly matching India's $89.6 million, according to a new study.

AI-generated summary

Why It Matters

India has historically dominated the market for antimalarial drugs in hard-hit African countries.

Font size

China is challenging India’s long-held dominance of the African market for antimalarial drugs in 12 of the continent’s hardest-hit countries, according to a new study.

Last year, Chinese exports of antimalarial drugs reached US$89.3 million, nearly matching India’s US$89.6 million, according to Indian market research company Sol Gravitas.

The gap has closed significantly since 2021, when Indian exports stood at US$121 million compared with US$62.6 million for China.

Separately, the study examined Global Fund purchases for the same 12 countries plus Kenya between 2021 and 2025.

Open Questions

Which specific 12 countries were examined in the study?
What are the Global Fund purchase figures between 2021 and 2025?

How competition between Chinese and Indian firms could reshape Africa’s drug markets

Chinese antimalarial exports to 12 hard-hit African countries nearly matched India's last year, according to a new study.

Quick Look

AI-generated summary

Why It Matters

India has historically dominated the market for antimalarial drugs in hard-hit African countries.

Font size

China is challenging India’s long-held dominance of the African market for antimalarial drugs in 12 of the continent’s hardest-hit countries, according to a new study.

Last year, Chinese exports of antimalarial drugs reached US$89.3 million, nearly matching India’s US$89.6 million, according to Indian market research company Sol Gravitas.

The gap has closed significantly since 2021, when Indian exports stood at US$121 million compared with US$62.6 million for China.

Separately, the study examined Global Fund purchases for the same 12 countries plus Kenya between 2021 and 2025.

Open Questions

Which specific 12 countries were examined in the study?
What are the Global Fund purchase figures between 2021 and 2025?

How competition between Chinese and Indian firms could reshape Africa’s drug markets

Quick Look

Why It Matters

Open Questions

Related Topics

How competition between Chinese and Indian firms could reshape Africa’s drug markets

Quick Look

Why It Matters

Open Questions

Related Topics

Related Stories

Taiwan aims to be self-sufficient in 50% of its rare earth demand, setting a timetable to reduce the risk of China cutting off supply

Beware of buying the bottom and turning into buying the house? Gold avalanches nearly 30%, foreign media reveals the key to the next step

Name TSMC! Foreign media revealed that it is more worthy of investment than "this giant"

The United States introduces new laws to strengthen the review of investments in China, covering biotechnology, AI, supercomputing and other fields

China Power Construction Engineering Corporation rushed to support the earthquake relief work in Baqing, Tibet, and transported 40 sets of prefabricated houses and 100 sets of heaters

Yichang, Hubei: “Electrifying the Yangtze River” from blueprint to reality